FDA approves ViiV's Juluca dolutegravir/rilpivirine for HIV-1 infection

FDA approved Juluca dolutegravir/rilpivirine from ViiV Healthcare Ltd. (Brentford, U.K.) to treat HIV-1 infection. The agency said Juluca

Read the full 182 word article

User Sign In